Ontology highlight
ABSTRACT:
SUBMITTER: Lin L
PROVIDER: S-EPMC6224799 | biostudies-other | 2018 Nov
REPOSITORIES: biostudies-other
Lin Li L He Xiubin X Zhao Tianyuan T Gu Lingkai L Liu Yeqing Y Liu Xiaoyu X Liu Hongyan H Yang Fayu F Tu Mengjun M Tang Lianchao L Ge Xianglian X Liu Changbao C Zhao Junzhao J Song Zongming Z Qu Jia J Gu Feng F
Molecular therapy : the journal of the American Society of Gene Therapy 20180901 11
FnCpf1-mediated genome-editing technologies have enabled a broad range of research and medical applications. Recently, we reported that FnCpf1 possesses activity in human cells and recognizes a more compatible PAM (protospacer adjacent motif, 5'-KYTV-3'), compared with the other two commonly used Cpf1 enzymes (AsCpf1 and LbCpf1), which requires a 5'-TTTN-3' PAM. However, due to the efficiency and fidelity, FnCpf1-based clinical and basic applications remain a challenge. The direct repeat (DR) se ...[more]